FIELD: veterinary science; pharmaceutics.
SUBSTANCE: invention relates to a veterinary dosage form. Composition against canine ectoparasites contains carbamoyl benzamide phenyl isoxazoline (CBPI) of formula: 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methyl-N-[(2,2,2-trifluoroethylcarbamoyl)methyl]benzamide and D,L-methionine (DLM). Ratio of the CBPI content to the tablet weight is adapted for the convenience of administering the veterinary pharmaceutical product to dogs and makes 7.5–35% with the weight of tablets from 1.5 to 4 g for animals weighing from 2 to 56 kg.
EFFECT: invention provides creation of a preparation with reduced toxic effect of CBPI active substance on animal organism, as well as change of ratio of active substance to tablet weight for convenience of its giving to dogs of different live weight.
1 cl, 4 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
SOLID PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION BASED ON ISOOXAZOLINE COMPOUNDS | 2013 |
|
RU2772279C2 |
SOLID PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION BASED ON ISOXAZOLINE COMPOUNDS | 2013 |
|
RU2646483C2 |
SOFT CHEWABLE PHARMACEUTICAL PRODUCTS | 2013 |
|
RU2765231C2 |
SOFT CHEWING PHARMACEUTICAL PRODUCTS | 2013 |
|
RU2632965C2 |
PRODUCTION OF SEMI-PLASTIC PHARMACEUTICALS | 2013 |
|
RU2802429C2 |
ANTIPARASITIC USE OF ISOXAZOLINE COMPOUNDS | 2014 |
|
RU2673723C1 |
PRODUCTION OF SEMI-PLASTIC PHARMACEUTICAL PREPARATIONS | 2013 |
|
RU2695360C2 |
USE OF ISOXAZOLINE COMPOUNDS FOR DEMODECOSIS TREATMENT | 2015 |
|
RU2709198C2 |
POWDERED INSECTOACARICIDAL AGENT BASED ON MICROSTRUCTURED AMORPHOUS SILICA SUPPORT | 2019 |
|
RU2708083C1 |
ANTIPARASITIC COMPOUNDS WITH AN APPEALING FLAVOUR | 2019 |
|
RU2773154C1 |
Authors
Dates
2024-07-22—Published
2023-11-20—Filed